{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DOX delivery", "GSH-responsive", "combination cancer therapy", "prodrug micelle"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30624945", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "11"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "01", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.1021/acs.molpharmaceut.8b00862"], "Journal": {"ISSN": "1543-8392", "JournalIssue": {"Volume": "16", "Issue": "3", "PubDate": {"Year": "2019", "Month": "Mar", "Day": "04"}}, "Title": "Molecular pharmaceutics", "ISOAbbreviation": "Mol Pharm"}, "ArticleTitle": "Delivery of Doxorubicin from Hyaluronic Acid-Modified Glutathione-Responsive Ferrocene Micelles for Combination Cancer Therapy.", "Pagination": {"StartPage": "987", "EndPage": "994", "MedlinePgn": "987-994"}, "Abstract": {"AbstractText": ["A combination of different chemotherapy approaches can obtain the best response for many cancers. However, the greatest challenge is the development of a nanoparticle formulation that can encapsulate different chemotherapeutic agents to achieve the proper synergetic chemotherapy for the tumor. Here, amphiphilic ferrocenium-tetradecyl (Fe-C<sub>14</sub>) was constructed to form cationic micelles in an aqueous solution via self-assembly. Then, it was coated by hyaluronic acid (HA) through electrostatic interactions to generate HA-Fe-C<sub>14</sub> micelles. The HA-Fe-C<sub>14</sub> micelles were used to deliver doxorubicin (DOX), and it showed that the DOX could be released rapidly under a high-GSH tumor environment. The HA-Fe-C<sub>14</sub>/DOX micelles were able to accumulate efficiently in tumor and showed significant anticancer effect both in vitro and in vivo. These results suggest that HA-Fe-C<sub>14</sub>/DOX micelles are a useful drug delivery system that enhances synergic antitumor treatment effects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Mao", "ForeName": "Hong-Lin", "Initials": "HL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Qian", "ForeName": "Feng", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Li", "ForeName": "Shun", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Shen", "ForeName": "Jia-Wei", "Initials": "JW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Ye", "ForeName": "Cheng-Kun", "Initials": "CK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Hua", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiation Oncology , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Cancer Institute of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Zhang", "ForeName": "Long-Zhen", "Initials": "LZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province School of Life Science , Jiangsu Normal University , Xuzhou 221116 , P.R. China."}], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province School of Life Science , Jiangsu Normal University , Xuzhou 221116 , P.R. China."}], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}, {"Identifier": ["0000-0001-8533-1973"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Yu", "ForeName": "Ru-Tong", "Initials": "RT"}, {"Identifier": ["0000-0002-0473-0030"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Nervous System Diseases , Xuzhou Medical University , Xuzhou 221002 , P.R. China."}, {"Identifier": [], "Affiliation": "Brain Hospital , Affiliated Hospital of Xuzhou Medical University , Xuzhou 221002 , P.R. China."}], "LastName": "Liu", "ForeName": "Hong-Mei", "Initials": "HM"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mol Pharm", "NlmUniqueID": "101197791", "ISSNLinking": "1543-8384"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Ferrous Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Metallocenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Micelles"}, {"RegistryNumber": "03LY784Y58", "NameOfSubstance": "n-tetradecane"}, {"RegistryNumber": "12125-80-3", "NameOfSubstance": "ferrocenium"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "9004-61-9", "NameOfSubstance": "Hyaluronic Acid"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}, {"RegistryNumber": "U96PKG90JQ", "NameOfSubstance": "ferrocene"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Alkanes"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Drug Liberation"}, {"QualifierName": ["chemical synthesis", "chemistry"], "DescriptorName": "Ferrous Compounds"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glutathione"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hyaluronic Acid"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Metallocenes"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": [], "DescriptorName": "Micelles"}, {"QualifierName": ["pathology", "therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "PC-3 Cells"}, {"QualifierName": [], "DescriptorName": "Solubility"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Tumor Burden"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30624945", "10.1021/acs.molpharmaceut.8b00862"]}}]}